Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana I Duarte

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2026
Mitochondria-targeted antioxidant AntiOxBEN<sub>2</sub> prevents metabolic dysfunction-associated steatotic liver disease (MASLD) by enhancing fatty acid oxidation and mitochondrial bioenergeticsRicardo Amorim, Carina Magalhães, Ana I Duarte, et al.
ACS Chemical Neuroscience|July 22, 2022
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral SclerosisClaudia Albertini, Alessandra Salerno, Silvia Atzeni, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2026
Mitochondria-targeted antioxidant AntiOxBEN<sub>2</sub> prevents metabolic dysfunction-associated steatotic liver disease (MASLD) by enhancing fatty acid oxidation and mitochondrial bioenergeticsRicardo Amorim, Carina Magalhães, Ana I Duarte, et al.
ACS Chemical Neuroscience|July 22, 2022
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral SclerosisClaudia Albertini, Alessandra Salerno, Silvia Atzeni, et al.
Pageof 5